P/E Ratio (Price-to-Earnings Ratio) in Pharmaceuticals & Healthcare
How to interpret and apply p/e ratio (price-to-earnings ratio) specifically when analyzing pharmaceuticals & healthcare stocks in India.
Quick Recap: What is P/E Ratio (Price-to-Earnings Ratio)?
The P/E ratio measures how much investors pay for each rupee of a company's earnings. It's calculated by dividing the stock price by earnings per share (EPS).
P/E Ratio = Stock Price ÷ Earnings Per Share (EPS)
How P/E Ratio (Price-to-Earnings Ratio) Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical P/E20-40x
General benchmark: Varies by sector. IT: 20-35, Banking: 10-20, FMCG: 30-50 in India.
Example Pharmaceuticals & Healthcare Companies to Analyze
Use the Equiscale Screener → to filter pharmaceuticals & healthcare stocks by p/e ratio and other metrics.
Key Takeaways
- P/E Ratio (Price-to-Earnings Ratio) in pharmaceuticals & healthcare should be compared against sector peers, not the market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Always cross-check with other metrics. No single ratio tells the full story.